Pharmacy Times Editor-in-Chief

Will medication therapy management become a routine part of most dispensing pharmacists' activities, or will a select group of pharmacists handle this role?

Is the furor over biologic drugs more of the same-or is the science of biologic drug production such that the quality of generic products entering the market can't be trusted?

What lofty projects are you planning to undertake in 2011?

The pharmacy profession is on the cusp of major changes, but individual pharmacists must be willing to step up to the plate.

How will changes brought by the election affect the future of health care reform?

Is society ready for pharmacists to fulfill their potential as doctoral trained medication experts?

Some food for thought for pharmacists and their patients-is there a relationship between the obesity epidemic and the prevalence of gastrointestinal disorders?

Can external oversight, in the form of a voluntary accreditation program, prevent the pharmacy industry's equivalent to the Gulf oil spill?

Should well-trained pharmacy technicians assume more responsibility for nonjudgmental activities in the pharmacy?

Will medication therapy management become a routine part of most dispensing pharmacists' activities, or will a select group of pharmacists handle this role?

Pharmacy has a united voice during the health care reform debate, and now that HR 3590 has passed, pharmacy groups must continue to be heard.

As an increasing number of drugs make the Rx-to-OTC switch, an opportunity exists for pharmacists to take a more active role in the recommendation of OTC products.

As new schools of pharmacy are being considered around the country, the job market for pharmacy is tightening in the current economic climate.

Who in the health profession should take ownership of the adherence problem? The problem is a complex one with studies that support the significant role the pharmacist can offer.

Despite tough economic times, the determination and patient care skills of community pharmacists are increasing demand for their services.

Mr. Eckel is professor at the Eshelman School of Pharmacy, University of North Carolina at Chapel Hill.